Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection : the Scan Study

To evaluate the safety and effectiveness of once-daily didanosine and nevirapine plus twice-daily stavudine versus twice-daily administration of all three drugs. This open-label, randomized, multicentre study enrolled 94 antiretroviral-naive patients with chronic HIV infection, CD4+ cell counts >...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	AIDS (London) 2000-11, Vol.14 (16), p.2485-2494
Hauptverfasser:	GARCIA, Felipe, KNOBEL, Hernando, CRUCETA, Anna, GALLART, Teresa, PUMAROLA, Tomas, MIRO, Jose M, GATELL, Jose M, SAMBEAT, Maria Antonia, ARRIZABALAGA, Julio, ARANDA, Miquel, ROMEU, Joan, DALMAU, David, SEGURA, Ferran, GOMEZ-SIRVENT, Juan Luis, FERRER, Elena
Format:	Artikel
Sprache:	eng
Schlagworte:	AIDS/HIV Anti-HIV Agents - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Biological and medical sciences CD4 antigen CD4 Lymphocyte Count Didanosine - therapeutic use Drug Resistance, Microbial - genetics Drug Therapy, Combination HIV Infections - drug therapy HIV Infections - virology HIV-1 - drug effects HIV-1 - genetics HIV-1 - physiology Human immunodeficiency virus 1 Humans Medical sciences Nevirapine Nevirapine - therapeutic use Palatine Tonsil - virology Pharmacology. Drug treatments Pilot Projects Reverse Transcriptase Inhibitors - therapeutic use RNA, Viral - analysis RNA, Viral - blood Stavudine Stavudine - therapeutic use T-Lymphocyte Subsets - immunology Viral Load
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!